The Place of Adoption in the NIDA Clinical Trials Network

scientific article

The Place of Adoption in the NIDA Clinical Trials Network is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/002204260803800408
P932PMC publication ID2814443
P698PubMed publication ID20126428
P5875ResearchGate publication ID41401433

P50authorJoseph GuydishQ47817738
P2093author name stringBarbara Tajima
Martha A Jessup
Sarah Turcotte Manser
P2860cites workAssessing competence in the use of motivational interviewingQ48497252
Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusersQ48611230
The toughest job you'll ever love: a Pacific Northwest Treatment Workforce Survey.Q52282525
Bridging Psychosocial Research and Treatment in Community Substance Abuse ProgramsQ58284152
Effective technology transfer in alcoholism treatmentQ73346527
Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transitionQ73740220
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkQ24548339
Stakeholders in recovery: demands, expectations, and research opportunitiesQ33774922
Multi-Level Assessment Protocol (MAP) for Adoption in Multisite Clinical TrialsQ34161793
Brief strategic family therapy: lessons learned in efficacy research and challenges to blending research and practiceQ34713567
Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatmentQ35074748
Strategies to encourage adoption in multisite clinical trials.Q35950120
Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.Q36627877
Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness studyQ36662456
Assessing and enhancing readiness for change: implications for technology transfer.Q40965503
Diffusion of drug abuse prevention programs: spontaneous diffusion, agenda setting, and reinventionQ40965541
Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behavior.Q43620003
Training rural practitioners to use buprenorphine; using The Change Book to facilitate technology transferQ44829776
Characteristics of opinion leaders in substance abuse treatment agenciesQ44844011
The gap between research and practice in substance abuse treatmentQ46554699
Prize-based contingency management does not increase gamblingQ46867632
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network studyQ46930765
Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphineQ46991043
Modeling the use of innovations in private treatment organizations: the role of absorptive capacityQ47293358
Staff beliefs about addiction treatmentQ47612604
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1083
P577publication date2008-01-01
P1433published inJournal of Drug IssuesQ15765803
P1476titleThe Place of Adoption in the NIDA Clinical Trials Network
P478volume38

Reverse relations

cites work (P2860)
Q377746182010: U.S. drug and alcohol policy, looking back and moving forward
Q35950131Adoption of motivational interviewing and motivational enhancement therapy following clinical trials

Search more.